IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
The availability of a highly purified and well characterized circumsporozoite protein (CSP) is essential to improve upon the partial success of recombinant CSP-based malaria vaccine candidates. Soluble, near full-length, Plasmodium falciparum CSP vaccine antigen (CS/D) was produced in E. coli under...
Main Authors: | Robert Schwenk, Margot DeBot, Michael Porter, Jennifer Nikki, Lisa Rein, Roberta Spaccapelo, Andrea Crisanti, Paul D Wightman, Christian F Ockenhouse, Sheetij Dutta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4208815?pdf=render |
Similar Items
-
Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.
by: Farhat Khan, et al.
Published: (2015-01-01) -
Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.
by: Remko Schats, et al.
Published: (2015-01-01) -
Seroprevalence of Antibodies against Plasmodium falciparum Sporozoite Antigens as Predictive Disease Transmission Markers in an Area of Ghana with Seasonal Malaria Transmission.
by: Kwadwo A Kusi, et al.
Published: (2016-01-01) -
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
by: Liriye Kurtovic, et al.
Published: (2018-04-01) -
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
by: Merricka C. Livingstone, et al.
Published: (2021-03-01)